1. Home
  2. LEXX vs BYFC Comparison

LEXX vs BYFC Comparison

Compare LEXX & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • BYFC
  • Stock Information
  • Founded
  • LEXX 2004
  • BYFC 1946
  • Country
  • LEXX Canada
  • BYFC United States
  • Employees
  • LEXX 7
  • BYFC N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • LEXX Health Care
  • BYFC Finance
  • Exchange
  • LEXX Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • LEXX 38.9M
  • BYFC 64.1M
  • IPO Year
  • LEXX N/A
  • BYFC 1996
  • Fundamental
  • Price
  • LEXX $2.23
  • BYFC $7.07
  • Analyst Decision
  • LEXX Strong Buy
  • BYFC
  • Analyst Count
  • LEXX 2
  • BYFC 0
  • Target Price
  • LEXX $11.00
  • BYFC N/A
  • AVG Volume (30 Days)
  • LEXX 202.4K
  • BYFC 7.4K
  • Earning Date
  • LEXX 01-10-2025
  • BYFC 10-29-2024
  • Dividend Yield
  • LEXX N/A
  • BYFC N/A
  • EPS Growth
  • LEXX N/A
  • BYFC N/A
  • EPS
  • LEXX N/A
  • BYFC 0.28
  • Revenue
  • LEXX $464,278.00
  • BYFC $35,113,000.00
  • Revenue This Year
  • LEXX $20.39
  • BYFC N/A
  • Revenue Next Year
  • LEXX $113.25
  • BYFC N/A
  • P/E Ratio
  • LEXX N/A
  • BYFC $24.51
  • Revenue Growth
  • LEXX 105.24
  • BYFC 12.14
  • 52 Week Low
  • LEXX $1.20
  • BYFC $4.41
  • 52 Week High
  • LEXX $6.85
  • BYFC $7.99
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.23
  • BYFC 51.85
  • Support Level
  • LEXX $2.00
  • BYFC $7.01
  • Resistance Level
  • LEXX $2.54
  • BYFC $7.16
  • Average True Range (ATR)
  • LEXX 0.24
  • BYFC 0.19
  • MACD
  • LEXX -0.00
  • BYFC -0.02
  • Stochastic Oscillator
  • LEXX 27.06
  • BYFC 64.15

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: